Metformin OK in CKD?

Drug and Therapeutics Bulletin

Volumn 52, Issue 4, 2014, Pages 37-

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; METFORMIN; SULFONYLUREA DERIVATIVE;

ACUTE KIDNEY FAILURE; CARDIOPULMONARY INSUFFICIENCY; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG EXPOSURE; GLOMERULUS FILTRATION RATE; HUMAN; HYPOXEMIA; LACTIC ACIDOSIS; NOTE; SYSTEMATIC REVIEW (TOPIC);

EID: 84898877805     PISSN: 00126543     EISSN: 17555248     Source Type: Journal    
DOI: 10.1136/dtb.2014.4.0244     Document Type: Note

References (8)

1. UKPDS Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998. 352 854-65.
2. Joint Formulary Committee. British National Formulary. Edition 67. London: BMJ Group and Pharmaceutical Press, March 2014.
3. Stades A et al. Metformin and lactic acidoisis in the setting of mild-to-moderate renal insufficiency. Diabetes Care 2004; 34: 179-87.
4. Salpeter S et al. Risks of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2010; 4: CD002967. DOI:10.1002/14651858. CD002967.pub4 [Last assessed as up-to-date 7 October 2009].
5. Bodmer M et al. Metformin, sulphonylureas, or other antidiabetes drugs and risk of lactic acidosis or hypoglycemia. Diabetes Care 2008; 31: 2086-91.
6. Glucophage 50mg and 850mg film coated tablets. Summary of Product Characteristics, UK. Merck Serono Ltd., October 2010.
7. National Institute for Health and Care Excellence, 2009. Type 2 diabetes: the management of type 2 diabetes (CG 87) [online]. Available: http://www.nice.org.uk/CG87 [Accessed 19 March 2014].
8. Ashley C, Currie A (Eds). The Renal Drug Handbook. Third edition. Oxford: Radcliffe Publishing, 2009.